Confronto

Buserelin vs. Carbetocin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

57982-77-1

37025-55-1

Peso molecolare

1239.42 g/mol

nessun dato

Emivita

nessun dato

0.67 h

Sequenza

nessun dato

Meccanismo d'azione

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Buserelin	Carbetocin
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Non approvato	Non approvato

Voci complete

Frequently asked questions

What is the difference between Buserelin and Carbetocin?: Buserelin is classified as "Ricerca (altro)", while Carbetocin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Carbetocin?: The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Carbetocin in Germany and the United States?: Germania: Buserelin — Su prescrizione, Carbetocin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Carbetocin — Non approvato. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Carbetocin

Germania

Su prescrizione

Stati Uniti

Non approvato

Frequently asked questions

What is the difference between Buserelin and Carbetocin?

Buserelin is classified as "Ricerca (altro)", while Carbetocin is classified as "Ricerca (altro)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Carbetocin?

The highest available evidence level is "RCT sull'uomo" for Buserelin and "RCT sull'uomo" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Carbetocin in Germany and the United States?

Germania: Buserelin — Su prescrizione, Carbetocin — Su prescrizione. Stati Uniti: Buserelin — Non approvato, Carbetocin — Non approvato. These are factual summaries with source and review date on the individual pages.